Special Issue "Bioactive Compounds on Mental Disorders"
Deadline for manuscript submissions: 31 December 2021.
Interests: depression; stress; resilience; post-traumatic stress disorder; aging
Special Issues, Collections and Topics in MDPI journals
Mental disorders are the leading cause of disability which continues to grow with significant impacts on health and major social, human rights and economic consequences in all countries of the world. Personal and social factors are attributable to mental health in combination with stress, nutrition, infection, and genetic factors. Studies have revealed many divergent biological systems that are implicated in the pathophysiology of mental disorders and provided numerous pharmacological targets. Many central nervous system acting drugs have been developed and are in use for treatment.
Nevertheless, the exact pathogenesis of most mental disorders is not known, and therapeutic reagents have many problems, such as suboptimal effect, high recurrence, multiple side effects, and requiring long-term administration. Accordingly, there is a need of novel drugs with improved effects.
This Special Issue “Bioactive Compounds on Mental Disorders” aims to gather contributions from basic scientists and clinical researchers to examine the issue of novel bioactive molecules with therapeutic effects on mental disorders.
Notes: The focus of this issue is describing the mechanism of bioactive molecules in improving mental disorders. We welcome submissions and studies on nutritional applications using biological, chemical, cellular, molecular, and immunological methods.
Prof. Dr. Sungho Maeng
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- natural products
- stress disorders
- bipolar disorder
- mental health